NO852446L - Fremgangsmaate for fremstilling av krystallinsk kalsium-pseudomonat eller hydrat derav. - Google Patents

Fremgangsmaate for fremstilling av krystallinsk kalsium-pseudomonat eller hydrat derav.

Info

Publication number
NO852446L
NO852446L NO852446A NO852446A NO852446L NO 852446 L NO852446 L NO 852446L NO 852446 A NO852446 A NO 852446A NO 852446 A NO852446 A NO 852446A NO 852446 L NO852446 L NO 852446L
Authority
NO
Norway
Prior art keywords
hydrate
preparation
procedure
crystalline calcium
calcium pseudomonate
Prior art date
Application number
NO852446A
Other languages
English (en)
Other versions
NO171593C (no
NO171593B (no
Inventor
Geoffrey Baker
Merle Beal
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10562629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO852446(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of NO852446L publication Critical patent/NO852446L/no
Publication of NO171593B publication Critical patent/NO171593B/no
Publication of NO171593C publication Critical patent/NO171593C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Electroluminescent Light Sources (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Sanitary Device For Flush Toilet (AREA)
  • Liquid Crystal Substances (AREA)
NO852446A 1984-06-19 1985-06-17 Fremgangsmaate for fremstilling av krystallinsk kalsium-pseudomonat eller et hydrat derav NO171593C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848415579A GB8415579D0 (en) 1984-06-19 1984-06-19 Compounds

Publications (3)

Publication Number Publication Date
NO852446L true NO852446L (no) 1985-12-20
NO171593B NO171593B (no) 1992-12-28
NO171593C NO171593C (no) 1993-04-07

Family

ID=10562629

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852446A NO171593C (no) 1984-06-19 1985-06-17 Fremgangsmaate for fremstilling av krystallinsk kalsium-pseudomonat eller et hydrat derav

Country Status (27)

Country Link
US (5) US4916155A (no)
EP (1) EP0167856B1 (no)
JP (1) JPH0723373B2 (no)
KR (1) KR930002509B1 (no)
AT (1) ATE49600T1 (no)
AU (1) AU577595B2 (no)
CA (1) CA1242437A (no)
DE (1) DE3575428D1 (no)
DK (1) DK164506C (no)
ES (1) ES8604249A1 (no)
FI (2) FI84179C (no)
GB (1) GB8415579D0 (no)
GR (1) GR851470B (no)
HU (1) HU195515B (no)
IE (1) IE58118B1 (no)
IL (1) IL75536A (no)
JO (1) JO1420B1 (no)
MX (1) MX163401B (no)
MY (1) MY102549A (no)
NO (1) NO171593C (no)
NZ (1) NZ212433A (no)
PH (1) PH22951A (no)
PL (1) PL254033A1 (no)
PT (1) PT80657B (no)
YU (1) YU45724B (no)
ZA (1) ZA854549B (no)
ZM (1) ZM4185A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US5273998A (en) * 1990-05-11 1993-12-28 Yoshitomi Pharmaceutical Industries, Ltd. Process for making an optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compound
GB9507825D0 (en) * 1995-04-18 1995-05-31 Wet Pieter M De Method of treatment
GB9616208D0 (en) 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
JP2001504091A (ja) * 1996-10-01 2001-03-27 スミスクライン・ビーチャム・コーポレイション 病原性生物による鼻咽腔のコロニー形成に関連する細菌感染の治療のための薬剤の製造のためのミュピロシンの使用
CO4910145A1 (es) 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
US6509177B1 (en) * 1999-02-03 2003-01-21 Biogal Gyogyszergyar Rt. Process for the preparation of pseudomonic acid A antibiotic by microbiological method
TR200403211T3 (tr) * 2001-06-21 2005-02-21 Biogal Gyogyszergyar Rt Psödomonik asit üretimi için metabolik olarak kontrol edilen fermantasyon işlemi.
EP1455769A4 (en) * 2001-12-28 2004-09-22 Biogal Gyogyszergyar METHOD FOR PRODUCING CRYSTALLINE AND AMORPHIC MUPIROCIN CALCIUM
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
WO2005009336A2 (en) * 2003-05-01 2005-02-03 Replidyne, Inc. Antibacterial methods and compositions
DK1641438T3 (da) * 2004-06-01 2010-06-07 Teva Gyogyszergyar Zartkoeruen Fremgangsmåde til fremstilling af den amorfe form af et lægemiddel
AU2006215708B2 (en) * 2005-02-21 2011-01-27 Syngen Biotech Co., Ltd Purification of mupirocin
US8076370B2 (en) * 2005-05-03 2011-12-13 Ranbaxy Laboratories Limited Antimicrobial agents
EP1752516A1 (en) * 2005-08-01 2007-02-14 The Lubrizol Corporation Dispersants
GB2441328A (en) * 2006-08-30 2008-03-05 Alpharma Aps A method for obtaining mupirocin calcium
WO2009092991A1 (en) * 2008-01-24 2009-07-30 Pliva Hrvatska D.O.O. Process for preparing crystalline calcium mupirocin dihydrate
WO2010132833A1 (en) * 2009-05-14 2010-11-18 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
WO2012014109A1 (en) 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Heterocyclic sulfonamides as inhibitors of transfer rna synthetase for use as antibacterial agents
WO2016133471A1 (en) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. A topical composition comprising mupirocin and dexpanthenol
KR102101297B1 (ko) 2019-02-15 2020-05-26 주식회사 드림테크 급속 스팀 세척기 제어방법
KR102269617B1 (ko) 2020-10-27 2021-06-24 신현호 스팀 급속제조장치 및 그 제어방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1395907A (en) * 1971-06-12 1975-05-29 Beecham Group Ltd Antibiotics
US4071536A (en) * 1971-06-12 1978-01-31 Beecham Group Limited Antibiotics
GB1587058A (en) * 1976-06-15 1981-03-25 Beecham Group Ltd Oxiranylmethyltetrahydropyran derivatives
GB1577730A (en) * 1976-10-23 1980-10-29 Beecham Group Ltd Treatment of infections with pseudomonicacid salts or esters thereof
GB1577545A (en) * 1977-07-27 1980-10-22 Beecham Group Ltd Treatment of swine dysenter
CA1115699A (en) * 1978-05-20 1982-01-05 Alan D. Curzons Lithium pseudomonate and its preparation
GB2097670B (en) * 1981-03-11 1985-02-27 Beecham Group Ltd Growth promotor containing pseudomonic acid
GB8313035D0 (en) * 1983-05-12 1983-06-15 Beecham Group Plc Compound
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
US4892960A (en) * 1985-01-28 1990-01-09 International Minerals & Chemical Corp. Crystalline lysocellin compositions and method of making

Also Published As

Publication number Publication date
GB8415579D0 (en) 1984-07-25
PL254033A1 (en) 1986-04-22
US5191093A (en) 1993-03-02
HUT38654A (en) 1986-06-30
NZ212433A (en) 1988-08-30
AU4373485A (en) 1986-01-02
ES8604249A1 (es) 1986-01-16
DK164506C (da) 1992-11-23
US4916155A (en) 1990-04-10
FI913260A0 (fi) 1991-07-04
DK275585A (da) 1985-12-20
FI852407L (fi) 1985-12-20
GR851470B (no) 1985-11-25
KR860000291A (ko) 1986-01-27
EP0167856A2 (en) 1986-01-15
HU195515B (en) 1988-05-30
JPS6117583A (ja) 1986-01-25
JPH0723373B2 (ja) 1995-03-15
US5569672A (en) 1996-10-29
FI84179B (fi) 1991-07-15
MX163401B (es) 1992-05-11
PT80657B (en) 1987-05-04
DE3575428D1 (de) 1990-02-22
EP0167856A3 (en) 1986-11-26
IL75536A0 (en) 1986-01-31
FI88796C (fi) 1993-07-12
ZA854549B (en) 1986-05-28
AU577595B2 (en) 1988-09-29
PH22951A (en) 1989-02-03
ZM4185A1 (en) 1985-11-22
NO171593C (no) 1993-04-07
IE58118B1 (en) 1993-07-14
YU101385A (en) 1988-02-29
KR930002509B1 (ko) 1993-04-03
US5792790A (en) 1998-08-11
DK164506B (da) 1992-07-06
US5436266A (en) 1995-07-25
PT80657A (en) 1985-07-01
JO1420B1 (en) 1986-11-30
NO171593B (no) 1992-12-28
ES544329A0 (es) 1986-01-16
EP0167856B1 (en) 1990-01-17
IL75536A (en) 1989-01-31
CA1242437A (en) 1988-09-27
FI88796B (fi) 1993-03-31
ATE49600T1 (de) 1990-02-15
IE851506L (en) 1985-12-19
DK275585D0 (da) 1985-06-18
FI84179C (fi) 1991-10-25
MY102549A (en) 1992-07-31
YU45724B (sh) 1992-07-20
FI852407A0 (fi) 1985-06-17

Similar Documents

Publication Publication Date Title
NO852446L (no) Fremgangsmaate for fremstilling av krystallinsk kalsium-pseudomonat eller hydrat derav.
ATE126433T1 (de) Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
EG18551A (en) Derivatives of acylic acid useful as fungicides insecticides,nematocides and plant growth regulators
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
NO884071D0 (no) Avisingsblandinger omfattende calsiummagnesiumacetatdobbeltsalt, samt fremgangsmaater for fremstilling derav.
IT8420123A0 (it) Procedimento di preparazione di acido fosforico e di solfato di calcio.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
DE58903876D1 (de) Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz.
NO893256L (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
IL84889A0 (en) Salts of pyrophosphorous acid,their preparation and their use as microbicides
IL70620A0 (en) Azolylpropane derivatives,their preparation and their use as plant growth regulants
DK268487A (da) Alkoxyalkyl- og alkylmercaptoalkylsubstituerede, bicycliske benzofuroisoquinoliner eller syreadditionssalte deraf og deres anvendelse
DE3689562D1 (de) Verfahren zur Erzeugung des menschlichen Wachstumhormons.
NO870739L (no) Renset human angiogen faktor og fremgangsmŸte for dens fremstilling.
ATE87309T1 (de) Azol-derivate verwendbar zur kontrolle von pflanzenkrankheiten und regulierung von pflanzenwachstum.
MX156014A (es) Procedimiento para preparar la sal de calcio del acido beta(4,5-difenil-oxasol-2-il) propionico
ES512680A0 (es) Procedimiento de preparacion de la sal de calcio del acido 2,5-dihidroxibencenosulfonico.
IT1224693B (it) Procedimento per la produzione difosfati cristallini di titanio, di zirconio e misti di zirconio e titanio